User profiles for "author:M Miller"

ML Miller

- Verified email at liquid2.vc - Cited by 61348

Martin R Miller

- Verified email at bham.ac.uk - Cited by 48084

Martin L Miller

- Verified email at astrazeneca.com - Cited by 24897

[HTML][HTML] Suicide risk and prevention during the COVID-19 pandemic

…, S Liu, S McManus, L Mehlum, M Miller… - The Lancet …, 2020 - thelancet.com
The mental health effects of the coronavirus disease 2019 (COVID-19) pandemic might be
profound1 and there are suggestions that suicide rates will rise, although this is not …

The CDF detector: an overview

…, A Menzione, T Meyer, S Mikamo, M Miller… - Nuclear Instruments and …, 1988 - Elsevier
Abstract The Collider Detector at Fermilab (CDF) is a 5000 t magnetic detector built to study
2 TeV pp collisions at the Fermilab Tevatron. Event analysis is based on charged particle …

Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement

BL Graham, I Steenbruggen, MR Miller… - American journal of …, 2019 - atsjournals.org
Background: Spirometry is the most common pulmonary function test. It is widely used in the
assessment of lung function to provide objective information used in the diagnosis of lung …

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

…, GA Mensah, TR Merriman, C Michaud, M Miller… - The lancet, 2012 - thelancet.com
Background Reliable and timely information on the leading causes of death in populations,
and how these are changing, is a crucial input into health policy debates. In the Global …

[PDF][PDF] The immune landscape of cancer

…, T Knijnenburg, R Kramer, K Leinonen, M Miller… - Immunity, 2018 - cell.com
We performed an extensive immunogenomic analysis of more than 10,000 tumors
comprising 33 diverse cancer types by utilizing data compiled by TCGA. Across cancer …

[HTML][HTML] Circulating tumor cells, disease progression, and survival in metastatic breast cancer

M Cristofanilli, GT Budd, MJ Ellis… - … England Journal of …, 2004 - Mass Medical Soc
Background We tested the hypothesis that the level of circulating tumor cells can predict
survival in metastatic breast cancer. Methods In a prospective, multicenter study, we tested …

[PDF][PDF] An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics

…, T Knijnenburg, R Kramer, K Leinonen, Y Liu, M Miller… - Cell, 2018 - cell.com
Summary For a decade, The Cancer Genome Atlas (TCGA) program collected
clinicopathologic annotation data along with multi-platform molecular profiles of more than …

[PDF][PDF] Integrated genomic characterization of papillary thyroid carcinoma

…, S Meng, M Meyerson, PA Mieczkowski, M Miller… - Cell, 2014 - cell.com
Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. Here, we
describe the genomic landscape of 496 PTCs. We observed a low frequency of somatic …

Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

NA Rizvi, MD Hellmann, A Snyder, P Kvistborg… - Science, 2015 - science.org
Immune checkpoint inhibitors, which unleash a patient's own T cells to kill tumors, are
revolutionizing cancer treatment. To unravel the genomic determinants of response to this …

[PDF][PDF] Oncogenic signaling pathways in the cancer genome atlas

…, T Knijnenburg, R Kramer, K Leinonen, Y Liu, M Miller… - Cell, 2018 - cell.com
Genetic alterations in signaling pathways that control cell-cycle progression, apoptosis, and
cell growth are common hallmarks of cancer, but the extent, mechanisms, and co …